News

Eurofins has earned ISO/IEC 17065:2012 accreditation for its Good Manufacturing Practices certification programme.
Explore how idiopathic pulmonary fibrosis could be a key model for testing ageing drugs and addressing age-related diseases.
Discover how researchers are measuring boron uptake in tumour cells to enhance cancer treatment techniques and patient care.
Find out how collaboration between MDC and KCL is addressing the challenges of glioblastoma with advanced cancer treatment techniques.
Scientists have developed a new computational model that reveals how the striosomal compartment of the brain’s striatum influences decision-making – which could lead to improved therapies for ...
Scientists have developed a new computational model that reveals how the striosomal compartment of the brain’s striatum influences decision-making – which could lead to improved therapies for ...
Developing robust potency assays for Antibody-Drug Conjugates (ADCs) is crucial for ensuring their clinical success, but designing assays that meet both technical and regulatory standards is ...
Researchers at UNSW Sydney have unveiled a next-generation CRISPR tool that could lead to safer treatments for genetic disorders, including Sickle Cell. A new generation of CRISPR technology developed ...
New preclinical research suggests that evenamide – a glutamate modulator – targets hippocampal hyperexcitability, potentially addressing positive, negative and cognitive symptoms of schizophrenia.
An existing asthma drug has been shown to almost completely prevent life-threatening allergic reactions to food in mice, after researchers found a previously unknown genetic pathway linked to ...
Researchers have developed a 3D-printed ‘skin in a syringe’, using a patient’s own cells to create functional dermis that could change the way we treat severe burns.
An interview with Thibault Géoui reveals why this technology wave might finally break through pharma’s productivity crisis – and why it will take longer than the optimists claim. The pharmaceutical ...